Seeking Justice Beyond the Settlement: A Handful of Holdouts Challenge Risperdal Agreement
Philadelphia, PA – Thousands of individuals have agreed to a settlement concerning the drug Risperdal, marketed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. However, a small group has opted out, choosing instead to pursue their cases in court over the drug’s alleged side effects, including gynecomastia, a condition characterized by breast enlargement in men. Janssen Pharmaceuticals has faced criticism and legal action over its marketing practices and failure to fully disclose the side effect risks of Risperdal. This antipsychotic drug has been used in the treatment of various psychological disorders, including bipolar disorder, … Read more